Top Markets
Coin of the day
Immunotech Laboratories, Inc. Immunotech Laboratories, Inc.

Immunotech Laboratories, Inc.

IMMB
株式のランク #40594
Immunotech Laboratories, Inc. develops and commercializes proprietary proteins... Immunotech Laboratories, Inc. develops and commercializes proprietary proteins for use in treating human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), hepatitis, and other immuno-related disorders. Its flagship compound is ITV-1 (immune therapeutic vaccine), a suspension of irreversible pepsin fraction that is used in the treatment of HIV/AIDS and Hepatitis C, as well as to modulate the immune system. The company is headquartered in Monrovia, California. As of June 14, 2017, Immunotech Laboratories, Inc. operates as a subsidiary of Enzolytics, Inc.
株価
$0.0002
最終同期: 2026-08-12
時価総額
$114.99K
変化(1日)
0.00%
変化(1年)
100.00%
US
取引 Immunotech Laboratories, Inc. (IMMB)

カテゴリー

Immunotech Laboratories, Inc.(IMMB)の配当利回りの履歴
Immunotech Laboratories, Inc.(銘柄コード: IMMB)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Immunotech Laboratories, Inc.(IMMB)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)